Lopez Genghis H, McGowan Eunike C, McGrath Kelli A, Abaca-Cleopas Maria E, Schoeman Elizna M, Millard Glenda M, O'Brien Helen, Liew Yew-Wah, Flower Robert L, Hyland Catherine A
Clinical Services and Research, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia.
Red Cell Reference Laboratory, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia.
Transfusion. 2016 Sep;56(9):2322-30. doi: 10.1111/trf.13713. Epub 2016 Jul 8.
Blood donors whose red blood cells (RBCs) exhibit a partial RhD phenotype, lacking some D epitopes, present as D+ in routine screening. Such phenotypes can exhibit low-frequency antigens (LFAs) of clinical significance. The aim of this study was to describe the serologic and genetic profile for a blood donor with an apparent D+ phenotype carrying a variant RHD gene where D Exons 5 and 6 are replaced by RHCE Exon (5-6).
Anti-D monoclonal antibodies were used to characterize the presentation of RhD epitopes on the RBCs. RHD exon scanning and DNA sequencing of short- and long-range polymerase chain reaction amplicons were used to determine the RHD structure and sequence. Extended phenotyping for LFAs RH23 (D(W) ) and Rh32 was performed.
The donor serology profile was consistent with partial RhD epitope presentation. The donor was hemizygous for an RHD variant allele described as RHD*D-CE(5-6)-D hybrid. The RHCE gene insert is at least 3.868 kb with 5' and 3' breakpoints between IVS4 + 132-c.667 and IVS6 + 1960-IVS6 + 2099, respectively. The sequence for this hybrid was assigned GenBank Accession Number KT099190.2. The RBCs were RH23 (D(W) )+ and Rh32-.
A novel RHD*D-CE(5-6)-D hybrid allele encodes a partial RhD epitope and carries the LFA RH23 (D(W) ). This and the epitope profile resemble the partial DVa phenotype. Given that RBCs from this individual lack some RhD epitopes, there is an alloimmunization risk if the donor is exposed to D+ RBCs. Conversely, transfusions of RH23 (D(W) )+ cells to RH23 (D(W) )- recipients also pose an alloimmunization risk.
红细胞(RBC)呈现部分RhD表型、缺乏某些D抗原决定簇的献血者,在常规筛查中表现为D阳性。此类表型可能会呈现具有临床意义的低频抗原(LFA)。本研究的目的是描述一名具有明显D阳性表型、携带变异RHD基因(其中D外显子5和6被RHCE外显子替换(5-6))的献血者的血清学和基因特征。
使用抗-D单克隆抗体来表征RBC上RhD抗原决定簇的呈现情况。采用RHD外显子扫描以及短程和长程聚合酶链反应扩增子的DNA测序来确定RHD结构和序列。对低频抗原RH23(D(W))和Rh32进行了扩展表型分析。
献血者血清学特征与部分RhD抗原决定簇呈现情况一致。该献血者对于一个被描述为RHD*D-CE(5-6)-D杂合子的RHD变异等位基因是半合子。RHCE基因插入片段至少为3.868 kb,5'和3'断点分别位于IVS4 + 132-c.667和IVS6 + 1960-IVS6 + 2099之间。该杂合子的序列被赋予GenBank登录号KT099190.2。RBC为RH23(D(W))阳性且Rh32阴性。
一种新型的RHD*D-CE(5-6)-D杂合等位基因编码部分RhD抗原决定簇并携带低频抗原RH23(D(W))。这以及抗原决定簇特征类似于部分DVa表型。鉴于该个体的RBC缺乏一些RhD抗原决定簇,如果该献血者接触D阳性RBC,则存在同种免疫的风险。相反,将RH23(D(W))阳性细胞输注给RH23(D(W))阴性受血者也会带来同种免疫的风险。